mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |